NZ Genitourinary Cancers Research Review Issue 2

In this issue:
  -  Fifteen-year prostate cancer outcomes after monitoring, surgery, or radiotherapy
  -  Cabozantinib + nivolumab and ipilimumab in RCC
  -  Radiation-based therapy for MIBC
  -  Metastatic bladder cancer expression and localisation of nectin-4 and trop-2
  -  Very long-term remission with high-risk localised prostate cancer
  -  Late relapse of germ cell tumours after prior chemotherapy
  -  Inflammation biomarkers in penile SCC
  -  Abiraterone + enzalutamide for metastatic prostate cancer
  -  Belzutifan + cabozantinib for advanced clear cell RCC
  -  Transcriptomic and clinical heterogeneity of metastatic disease timing in mCSPC

Please login below to download this issue (PDF)